Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy

Annals of Surgical Oncology

Volumn 7, Issue 10, 2000, Pages 727-731

  Luna Pérez, Pedro ^a   Segura, Julia ^b   Alvarado, Isabel ^a   Labastida, Sonia ^a   Santiago Payán, Héctor ^a   Quintero, Angelina ^b  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

K ras; Rectal cancer; Tumor markers

Indexed keywords

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELL ONCOGENE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; ONCOGENE K RAS; PREOPERATIVE PERIOD; PROGNOSIS; RECTUM CANCER; TUMOR CLASSIFICATION;

ADENOCARCINOMA; AGED; COMBINED MODALITY THERAPY; FEMALE; GENE EXPRESSION; GENES, RAS; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033635827     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0727-0     Document Type: Article

References (29)

1. A genetic model for colorectal tumorigenesis
2. Detection of high incidence of K-ras oncogenes during human colon tumorigenesis
3. K-ras gene mutation as a pathogenic and diagnostic marker in human cancer
4. Ras genes
5. Signal transduction. How receptor turns ras on
6. Prognostic significance of K-ras mutations in colorectal carcinoma
7. Determination of tumor aggressiveness in colorectal cancer by K-ras-2 analysis
8. The type of K-ras mutation determines prognosis in colorectal cancer
9. A newly identified pattern of k-ras mutations at codons 12 and 13 is associated with long-term survival in colorectal cancer
10. Determination of K-ras and p53 genes in colorectal cancer and their prognostic significance
11. K-ras mutations and prognosis in large-bowel carcinomas
12. Prognostic value of p53 overexpression and c-Ki-ras mutations in colorectal cancer
13. Ki-ras mutations and prognosis in colorectal cancer
14. Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer
15. Radiotherapy in addition to radical surgery in rectal cancer: Evidence for a doseresponse effect favoring preoperative treatment
16. Prognostic factors in patients with locally advanced rectal adenocarcinoma treated with preoperative radiotherapy and surgery
17. Modified cleating technique to identify lymph node metastases in post-irradiated surgical specimens from rectal adenocarcinoma
18. Prognostic factors of rectum carcinoma: Experience of the German Multicentre Study SGCRC
19. Symposium on rectal cancer: 2 Local recurrences after surgery for rectal cancer
20. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma
21. Apoptosis, proliferation, bax, bcl-2 and p53 status prior to and after preoperative radiochemotherapy for locally advanced rectal cancer
22. Mutant K-ras in apparently normal mucosa of colorectal cancer patients
23. Frequent and characteristic K-ras activation in aberrant crypt foci of colon: Is there preference among K-ras mutants for malignant progression?
24. K-ras mutations in putative preneoplastic lesions in the human colon
25. Genetic alterations during colorectal-tumor development
26. Stability of K-ras mutations throughout the natural history of human colorectal cancer
27. Prognostic implications of c-Ki-ras mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: A study of the Eastern Cooperative Oncology Group
28. Regional versus systemic chemotherapy in the treatment of colorectal carcinoma metastatic to the liver: Is there a survival difference? Meta-analysis of the published literature